Why the study?
Does metabolic syndrome independently predict angiographically significant CAD across different Framingham Risk Score categories?
Does metabolic syndrome independently predict angiographically significant CAD across different Framingham Risk Score categories?
Metabolic syndrome predicts angiographic CAD primarily in low-risk individuals, but its individual components like impaired fasting glucose are stronger predictors than the syndrome itself.
Answers are grounded in this paper and cite their sources.
May aid low-risk CAD stratification; leaves open whether the syndrome adds value beyond components across risk groups.
Metabolic syndrome is an independent determinant of angiographically significant CAD only among those individuals at low 10-year risk for future coronary events. Individual components of the syndrome, such as impaired fasting glucose, have a stronger association with CAD than the syndrome as a whole.
No takes yet. Share an insight, caveat, or question.
Konstantinou et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: